SCHEMBL10590860

SCHEMBL10590860

CC1=CC(=O)CC2=C1Nc1ccc(C)cc1S2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.47
▸ MAPT P10636 5/20 0.40
▸ MEN1 O00255 5/20 0.40
▸ KMT2A Q03164 5/20 0.40
▸ ALOX15 P16050 3/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ GAA P10253 3/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ NOX1 Q9Y5S8 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ POLB P06746 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ ALDH1A1 P00352 4/20 0.34
▸ USP2 O75604 1/20 0.34
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10591877 0.76 EPHX2 (0.48) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL10593297 0.75 EPHX2 (0.47) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL10593152 0.71 SNCA (0.52) MAPTMEN1KMT2AMAPK1GAA
SCHEMBL10590962 0.70 EPHX2 (0.41) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL12273608 0.70 MAPT (0.34) MAPTMEN1KMT2AMAPK1NOX1
SCHEMBL225916 0.69 MAPT (0.59) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL29640485 0.69 MAPT (0.59) EPHX2MAPTMEN1KMT2AALOX15
SCHEMBL12272766 0.69 — —
SCHEMBL12273730 0.66 HSD17B10 (0.35) MAPTMEN1KMT2AALOX15HSD17B10
SCHEMBL12273519 0.66 MAPT (0.31) MAPTMEN1KMT2AMAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0115394-B1 PHENOTHIAZONE DERIVATIVES AND ANALOGS MERCK FROSST CANADA INC. (CA) 1989-06-28 — — EP disclosed
EP-0155623-A2 Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
EP-0115394-A2 Phenothiazone derivatives and analogs MERCK FROSST CANADA INC. (CA) 1984-08-08 — — EP disclosed
Send feedback